Clinical Scorecard: Management of Ulcerated Scrotal Infantile Hemangioma in an Infant Using Systemic Propranolol and Topical Moist Dressings: A Case Study
At a Glance
Category
Detail
Condition
Ulcerated Infantile Hemangioma (UIH)
Key Mechanisms
Systemic propranolol and customized moist wound healing strategy
Target Population
Infants, particularly those with hemangiomas in high-risk areas like the scrotum
Care Setting
Outpatient care with initial monitoring in a day-care ward
Key Highlights
Successful management of ulcerated scrotal infantile hemangioma using propranolol and moist dressings
Complete epithelialization achieved within 12 days
No significant hypertrophic scarring observed at 3-month follow-up
Parents trained in aseptic dressing techniques for home care
Rapid clinical response with control of infection within 3 days
Guideline-Based Recommendations
Diagnosis
Clinical assessment of hemangioma characteristics and complications
Management
Systemic propranolol at a maintenance dose of 2 mg/kg/d
Moist wound healing strategy with alginate dressing and rhEGF gel
Monitoring & Follow-up
Continuous ECG monitoring during initial propranolol administration
Regular follow-up assessments via digital photographs for wound evaluation
Risks
Potential for bleeding, secondary infection, and scarring
Patient & Prescribing Data
5-month-old male infant with ulcerated scrotal hemangioma
Combination of systemic propranolol and tailored local wound care effectively managed ulceration and promoted healing
Clinical Best Practices
Implement a multimodal treatment approach for UIH
Educate caregivers on wound care techniques to ensure compliance
Utilize digital monitoring for ongoing assessment of wound healing
